Detalhe da pesquisa
1.
Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma.
Hepatology
; 77(3): 745-759, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243663
2.
Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway.
Pharmacol Res
; 200: 107082, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280440
3.
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Mol Cancer
; 21(1): 57, 2022 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189910
4.
PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.
J Hepatol
; 77(1): 163-176, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219791
5.
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma.
Cancer Cell Int
; 22(1): 128, 2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305624
6.
Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning.
Gut
; 70(5): 951-961, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998878
7.
CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity.
Mol Cancer
; 20(1): 75, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985545
8.
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.
Mol Cancer
; 19(1): 92, 2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430013
9.
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Mol Cancer
; 19(1): 110, 2020 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32593303
10.
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
Hepatology
; 69(1): 143-159, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30070719
11.
Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
Gut
; 68(12): 2195-2205, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31358576
12.
Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning.
J Cell Mol Med
; 23(5): 3369-3374, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784182
13.
LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma.
J Cell Physiol
; 234(3): 2788-2794, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132868
14.
The long noncoding RNA NORAD enhances the TGF-ß pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p.
J Cell Physiol
; 234(7): 12051-12060, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537113
15.
Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.
Mol Cancer
; 23(1): 44, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424621
16.
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.
Mol Cancer
; 18(1): 105, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31153371
17.
Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression.
Cancer Sci
; 110(7): 2133-2144, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31066149
18.
Corrigendum to: "PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma" [J Hepatol 77 (2022) 163-176].
J Hepatol
; 78(4): 881-882, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564318
19.
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
J Hepatol
; 69(1): 89-98, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551704
20.
Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma.
J Pathol
; 243(4): 407-417, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28833123